Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells
Komaki R, Lee J, Milas L, Kaplan B, Allen P, Liao Z, Stevens C, Fossella F, Zinner R, Papadimitrakopoulou V, Khuri F, Herbst R, Kies M, Blumenschein G, Glisson B, Hong W, Morice R, Cox J. Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells. International Journal Of Radiation Oncology • Biology • Physics 2002, 54: 105. DOI: 10.1016/s0360-3016(02)03237-6.Peer-Reviewed Original ResearchNon-small cell lung cancerInoperable non-small cell lung cancerPhase III trialsCell lung cancerIII trialsLung cancerCancer cellsAmifostineChemoradiationCancerTrials